173 related articles for article (PubMed ID: 18665245)
1. Epithelial ovarian cancer: the role of cell cycle genes in the different histotypes.
D'Andrilli G; Giordano A; Bovicelli A
Open Clin Cancer J; 2008 Feb; 2():7-12. PubMed ID: 18665245
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle genes in ovarian cancer: steps toward earlier diagnosis and novel therapies.
D'Andrilli G; Kumar C; Scambia G; Giordano A
Clin Cancer Res; 2004 Dec; 10(24):8132-41. PubMed ID: 15623586
[TBL] [Abstract][Full Text] [Related]
3. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
5. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
Aunoble B; Sanches R; Didier E; Bignon YJ
Int J Oncol; 2000 Mar; 16(3):567-76. PubMed ID: 10675491
[TBL] [Abstract][Full Text] [Related]
6. Global gene expression profiles of ovarian surface epithelial cells in vivo.
Gava N; L Clarke C; Bye C; Byth K; deFazio A
J Mol Endocrinol; 2008 Jun; 40(6):281-96. PubMed ID: 18502821
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of ovarian cancers.
Berchuck A; Elbendary A; Havrilesky L; Rodriguez GC; Bast RC
J Soc Gynecol Investig; 1994; 1(3):181-90. PubMed ID: 9419769
[TBL] [Abstract][Full Text] [Related]
8. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
[TBL] [Abstract][Full Text] [Related]
9. Role of cell-cycle regulatory proteins in gynecological cancer.
Milde-Langosch K; Riethdorf S
J Cell Physiol; 2003 Aug; 196(2):224-44. PubMed ID: 12811815
[TBL] [Abstract][Full Text] [Related]
10. Expression and subcellular localization of maspin in human ovarian epithelial neoplasms: correlation with clinicopathologic features.
Abd El-Wahed MM
J Egypt Natl Canc Inst; 2005 Sep; 17(3):173-83. PubMed ID: 16799655
[TBL] [Abstract][Full Text] [Related]
11. Rare ovarian tumors: an update on diagnosis and treatment.
Debuquoy C; Romeo C; Vanacker H; Ray-Coquard I
Int J Gynecol Cancer; 2020 Jun; 30(6):879-887. PubMed ID: 32461259
[TBL] [Abstract][Full Text] [Related]
12. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
13. Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors.
Masciullo V; Valdivieso P; Amadio G; Santoro A; Angelico G; Sgambato A; Boffo S; Giordano A; Scambia G; Zannoni GF
Front Med (Lausanne); 2020; 7():596226. PubMed ID: 33262995
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes in high grade serous adenocarcinoma of the ovary.
Manasa P; Sidhanth C; Krishnapriya S; Vasudevan S; Ganesan TS
Genes Cancer; 2020 Dec; 11(3-4):122-136. PubMed ID: 33488950
[TBL] [Abstract][Full Text] [Related]
15. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.
Nunez MI; Rosen DG; Ludes-Meyers JH; Abba MC; Kil H; Page R; Klein-Szanto AJ; Godwin AK; Liu J; Mills GB; Aldaz CM
BMC Cancer; 2005 Jun; 5():64. PubMed ID: 15982416
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
Fazi F; Blandino G
Microrna; 2013; 2(2):81. PubMed ID: 25070777
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
18. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
Kurman RJ
Ann Oncol; 2013 Dec; 24 Suppl 10():x16-21. PubMed ID: 24265397
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in Ovarian Cancer.
Katz B; Tropé CG; Reich R; Davidson B
Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes.
Engqvist H; Parris TZ; Biermann J; Rönnerman EW; Larsson P; Sundfeldt K; Kovács A; Karlsson P; Helou K
Sci Rep; 2020 May; 10(1):7946. PubMed ID: 32409713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
